Projects & Partnerships

Enhancing the public health impact of latent TB infection diagnosis and treatment:

A pragmatic cluster randomized trial.

Click here to have more details on the protocol, material and publications associated with the study.

 

 

 

 

 

 

A randomized clinical trial of 4 months Rifampin vs. 9 months Isoniazid for latent TB infection (Phase 3 effectiveness) 

&

A randomized trial to compare completion and tolerability of 4 months Rifampin (4 RIF) and 9 months Isoniazid (9 INH) for treatment of latent TB in children

 

Click here to have more details on the protocol 

Click here to have access to the RCT 4v9 children publication

Click here to have access to the RCT 4v9 adult publication

 

 

 

 

                                                                       

Meta-analysis of Individual patient Data (IPD) of Patients with INH (mono or poly-drug) Resistant Tuberculosis

Click here to read the study protocol

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Partnerships

PAHO/WHO Collaborating Centers

www.paho.org/collaboratingcenters

 

Advancing New TB Vaccines for the World

www.aeras.org/

Our vision: A world where diagnosis guides the way to health for all people

Our mission: Turning complex diagnostic challenges into simple solutions to overcome diseases of poverty and transform lives

www.finddx.org/

Manipal Centre for Infectious Disease based at Manipal University, Karnataka, India

https://manipal.edu/mu.html

SGC is a public-private partnership that supports the discovery of new medicines through open access research. 

www.thesgc.org/

TB REACH: FINDING AND TREATING PEOPLE WITH TB IN THE WORLD’S POOREST COMMUNITIES

www.stoptb.org/global/awards/tbreach/

 

Partnership involvement

TB Alliance is a not-for-profit organization dedicated to the discovery and development of better, faster-acting, and affordable tuberculosis drugs that are available to those who need them.

www.tballiance.org/